Cargando…
De-Differentiation Confers Multidrug Resistance Via Noncanonical PERK-Nrf2 Signaling
Malignant carcinomas that recur following therapy are typically de-differentiated and multidrug resistant (MDR). De-differentiated cancer cells acquire MDR by up-regulating reactive oxygen species (ROS)–scavenging enzymes and drug efflux pumps, but how these genes are up-regulated in response to de-...
Autores principales: | Del Vecchio, Catherine A., Feng, Yuxiong, Sokol, Ethan S., Tillman, Erik J., Sanduja, Sandhya, Reinhardt, Ferenc, Gupta, Piyush B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159113/ https://www.ncbi.nlm.nih.gov/pubmed/25203443 http://dx.doi.org/10.1371/journal.pbio.1001945 |
Ejemplares similares
-
Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1
por: Feng, Yu-Xiong, et al.
Publicado: (2017) -
Perturbation-Expression Analysis Identifies RUNX1 as a Regulator of Human Mammary Stem Cell Differentiation
por: Sokol, Ethan S., et al.
Publicado: (2015) -
Role of GCN2-Independent Signaling Through a Noncanonical PERK/NRF2 Pathway in the Physiological Responses to Dietary Methionine Restriction
por: Wanders, Desiree, et al.
Publicado: (2016) -
PERK prevents hepatic lipotoxicity by activating the p62-ULK1 axis-mediated noncanonical KEAP1-Nrf2 pathway
por: Lee, Da Hyun, et al.
Publicado: (2022) -
Identification and Characterization of PERK Activators by Phenotypic Screening and Their Effects on NRF2 Activation
por: Xie, Wensheng, et al.
Publicado: (2015)